Investing
“‘I’ve always told people there is nobody who can really pick the market on a short-term or an intermediate-term basis. Maybe I made the...
Hi, what are you looking for?
IntelTEXTA
IntelTEXTA
Investing
Don’t miss these top money and investing features: Sign up here to get MarketWatch’s highlights of the most timely ETF news emailed to you weekly....
Investing
In these times of deep divisions, one thing Americans can agree on is the Super Bowl. It has become our secular version of Carnival...
Investing
A glimmer of hope appeared Friday for beleaguered New York Community Bancorp after its stock rose 17% on strong trading volume. Investors seemed reassured...
Investing
Looks like MP3 players are still striking a chord in 2023. Microsoft is giving away an unopened Zune portable media player to promote Marvel’s...
Investing
When Andrew Pessano was looking to create a state-of-the-art indoor pickleball facility in southern New Jersey and take advantage of the surging interest in...
Investing
Gold futures finished higher on Friday after a three-session decline attributed in part to strength in the U.S. dollar, pulled prices for the precious...
Investing
Oil futures settled a bit lower on Friday, with prices for U.S. and global benchmark crude posting their first weekly gain in five weeks,...
Investing
By Denny Jacob Software maker VMware and Broadcom on Friday mutually agreed to extend their proposed merger deadline to Aug. 26. The companies may...
Investing
By Denny Jacob International stocks trading in New York closed mostly lower on Friday. The S&P/BNY Mellon index of American depositary receipts ticked up...
Investing
By Denny Jacob Logistec on Friday said its principal shareholder, Sumanic Investments, informed the board of its interest in considering a partial or whole...
Investing
By Denny Jacob GoHealth confirmed it received a proposal from Centerbridge Partners and NVX Holdings, its two largest shareholders, to acquire all outstanding Class...
Investing
By Josh Beckerman An Intercept Pharmaceuticals Inc. drug received two unfavorable votes from a Food and Drug Administration advisory committee. Intercept shares were halted...
